CA2640986A1 - Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels - Google Patents

Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels Download PDF

Info

Publication number
CA2640986A1
CA2640986A1 CA002640986A CA2640986A CA2640986A1 CA 2640986 A1 CA2640986 A1 CA 2640986A1 CA 002640986 A CA002640986 A CA 002640986A CA 2640986 A CA2640986 A CA 2640986A CA 2640986 A1 CA2640986 A1 CA 2640986A1
Authority
CA
Canada
Prior art keywords
composition
ocular
inflammatory
cytokine
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002640986A
Other languages
English (en)
Other versions
CA2640986C (fr
Inventor
Reza Dana
Mohammad Dastjerdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schepens Eye Research Institute Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2008/009776 external-priority patent/WO2009025763A2/fr
Publication of CA2640986A1 publication Critical patent/CA2640986A1/fr
Application granted granted Critical
Publication of CA2640986C publication Critical patent/CA2640986C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition ayant les moyens d'inhiber la fonction de la cytokine de l'inflammation IL-I et des procédés d'utilisation de cette composition pour traiter une maladie inflammatoire des annexes et des tissus oculaires par administration topique. La présente invention décrit également des dispositifs permettant d'administrer cette composition à des tissus cibles.
CA2640986A 2007-08-16 2008-08-15 Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels Active CA2640986C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96513507P 2007-08-16 2007-08-16
US60/965,135 2007-08-16
US13068708P 2008-06-02 2008-06-02
US61/130,687 2008-06-02
PCT/US2008/009776 WO2009025763A2 (fr) 2007-08-16 2008-08-15 Composition thérapeutique pour le traitement de l'inflammation des annexes et des tissus oculaires

Publications (2)

Publication Number Publication Date
CA2640986A1 true CA2640986A1 (fr) 2009-02-16
CA2640986C CA2640986C (fr) 2014-10-21

Family

ID=40374879

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2640986A Active CA2640986C (fr) 2007-08-16 2008-08-15 Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels

Country Status (1)

Country Link
CA (1) CA2640986C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112804990A (zh) * 2018-12-28 2021-05-14 罗尔夫·兰伯特博士制药咨询有限公司 一种脂质体滴眼液及其在治疗干眼症中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112804990A (zh) * 2018-12-28 2021-05-14 罗尔夫·兰伯特博士制药咨询有限公司 一种脂质体滴眼液及其在治疗干眼症中的应用
CN112804990B (zh) * 2018-12-28 2024-05-24 罗尔夫·兰伯特博士制药咨询有限公司 一种脂质体滴眼液及其在治疗干眼症中的应用

Also Published As

Publication number Publication date
CA2640986C (fr) 2014-10-21

Similar Documents

Publication Publication Date Title
AU2008289552B2 (en) Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
JP2011516400A5 (fr)
EP2242504B1 (fr) Compositions thérapeutiques utilisées pour le traitement des affections inflammatoires oculaires
Moysidis et al. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside
AU2010203425B2 (en) Therapeutic compositions for treatment of corneal disorders
Ambroziak et al. Immunomodulation on the ocular surface: a review
KR20190068575A (ko) 안구 표면 항상성의 확립, 회복 및 보존 방법
WO2016060916A1 (fr) Histatines en tant qu'agents thérapeutiques pour une maladie de la surface oculaire
Sherwood A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis)
US20120014970A1 (en) Therapeutic Compositions for Treatment of Corneal Disorders
CA2640986C (fr) Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels
AU2014227534B2 (en) Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
US11306140B2 (en) Therapeutics for ocular immunoinflammatory diseases
US20220288028A1 (en) A therapeutic approach for treating non-infectious ocular immunoinflammatory disorders
WO2018201002A1 (fr) Procédés et compositions pour réduire la perte de cellules endothéliales cornéennes
Gumus Topical Coenzyme Q10 Eye Drops as an Adjuvant Treatment in Challenging Refractory Corneal Ulcers: A Case Series and

Legal Events

Date Code Title Description
EEER Examination request